BioDlink International Company Limited (HKG:1875)
3.210
-0.010 (-0.31%)
Jul 31, 2026, 4:08 PM HKT
HKG:1875 Market Cap
HKG:1875 has a market cap or net worth of 2.48 billion as of July 31, 2026. Its market cap has increased by 17.15% in one year.
Market Cap
2.48B
Enterprise Value
2.54B
Revenue
831.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.21
ChartMarket Cap Chart
Since November 8, 2019, HKG:1875's market cap has decreased from 3.57B to 2.48B, a decrease of -30.48%. That is a compound annual growth rate of -5.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.48B | 28.40% |
| Dec 24, 2025 | 1.93B | 39.66% |
| Dec 31, 2024 | 1.38B | -9.14% |
| Dec 29, 2023 | 1.52B | -17.92% |
| Dec 30, 2022 | 1.85B | -29.40% |
| Dec 31, 2021 | 2.63B | -0.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Recbio Technology | 3.10B |
| HJ Science | 3.04B |
| Shandong Boan Biotechnology | 2.92B |
| Beijing Luzhu Biotechnology | 2.78B |
| TYK Medicines | 2.73B |
| Antengene Corporation | 2.63B |
| Viva Biotech Holdings | 2.61B |
| Frontage Holdings | 2.35B |